Skip to content

Clinical trials

Phase 3 Respiratory Tract Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 3 Country / region: Canada Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20111
20131
20144
20153
20163
20173
20182
20192
20201
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting3
Active, not recruiting1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Medicago3
Bellus Health Inc. - a GSK company2
United Therapeutics2
Vertex Pharmaceuticals Incorporated2
Daiichi Sankyo1
Eli Lilly and Company1
GlaxoSmithKline1
Merck Sharp & Dohme LLC1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases26
Lung Diseases18
Bronchial Diseases9
Lung Diseases, Obstructive9
Asthma8
Respiratory Tract Infections5
Influenza, Human4
Pathologic Processes4
RNA Virus Infections4
Virus Diseases4

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.